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The full-length LysR-type transcriptional regulator TsaR from Comamonas
testosteroni T-2 was heterologously overexpressed in Escherichia coli, purified
and stabilized under conditions that favoured its rapid crystallization using the
microbatch-under-oil technique. The purified protein was highly crystallizable
and two different crystal forms were readily obtained. However, only monoclinic
crystals gave diffraction beyond 2 A˚ and there was a slight variation in unit-cell
parameters between crystals. The only other LysR-type regulator for which a
full-length crystal form is available is CbnR, but no solution could be obtained
when this was used as a model in molecular replacement. Mercury and xenon
derivatives were therefore produced in order to phase the structure using a
MIRAS approach.
1. Introduction
TsaR is a 298-amino-acid protein that belongs to the LysR family of
transcriptional regulators (LTTR) and controls the expression of the
operon tsaMBCD in the soil bacterium Comamonas testosteroni T-2.
The tsaMBCD genes encode the enzymes required for the initial
desulfonation of p-toluenesulfonate, an industrial arylsulfonate and
major pollutant (Tralau et al., 2003). The initial desulfonation leads to
the formation of protocatechuate and is followed by oxidative ring
cleavage, thus allowing the organism to use p-toluenesulfonate as a
sole source of carbon and energy (Cook et al., 1999). This use of an
arylsulfonate as a carbon source contrasts with the alternative use of
arylsulfonates as a sulfur source by many other organisms, which is
upregulated under sulfate-limitation conditions (Kertesz, 2000). The
degradation of compounds as carbon and energy sources tends to be
regulated on the operon and gene level by individual regulators, while
transcriptional control under sulfate limitation is a coordinated
response of the CysB regulon and individual regulators (Van der
Ploeg et al., 1996). Characterization of the regulators for these
degradative pathways has merited attention owing to their biotech-
nological relevance for the bioremediation of polluted waste waters
and effluents from waste dumps.
LTTRs are the most common regulators in prokaryotes and have
been the subject of intense study ever since the term LTTR was first
introduced (Henikoff et al., 1988). They are characterized by two
main domains: an N-terminal domain with a winged helix–turn–helix
(wHTH) as a DNA-binding motif and a helix 30 residues in length
and a C-terminal region made up of two subdomains with /
Rossmann-fold topology. The full-length proteins are homo-
tetrameric in solution and their ability to bind to multiple sites within
a promoter region is mediated by the presence of a small coinducer,
which is often a metabolite of the pathway they regulate (Schell,
1993). Very few LTTR crystal structures have been obtained. This is
partly because of their general low solubility but presumably also
because of their inherent flexibility; they are composed of two distinct
domains joined by a flexible linker. Indeed, all but one of the LTTR
structures available have been determined using truncated forms of
the respective proteins and show only the C-terminal domain, as for
BenM (Ezezika et al., 2007) and DntR (Smirnova et al., 2004) among
other cases. The structure of CbnR is the only full-length crystal
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structure of a LysR regulator that has been determined to date
(Muraoka et al., 2003).
Here, we report that full-length TsaR displays high crystallizability
when it is purified and crystallized under conditions that stabilize the
protein in solution and allow the exclusion of air. We describe the
efforts made to resolve several problems that were encountered
during the process of crystallographic phasing, namely non-
isomorphism, as previously reported in the case of CysB phasing
(Verschueren et al., 1999), low substitution of heavy atoms and
incompleteness and anisotropy as a consequence of the low-
symmetry space group.
2. Materials and methods
2.1. Protein expression and purification
C-terminally His-tagged TsaR was heterologously overexpressed
in Escherichia coli M10 (Tralau et al., 2003). Cells were grown semi-
aerobically in LBmedium (1 l medium in 2 l Erlenmeyer flasks) in the
presence of kanamycin (25 mg ml1) and ampicillin (100 mg ml1) at
303 K and 180 rev min1. Overexpression was induced by the addi-
tion of 1 mM IPTG at an OD600 of 0.4. Cells were harvested by
centrifugation (30 000g, 277 K, 30 min) 2 h after induction, washed in
50 mM Tris–HCl pH 8.0 and stored at 253 K until further processing.
The pellet obtained from 2 l cell culture was resuspended in 40 ml
lysis buffer (20 mM Tris–HCl pH 7.0, 0.3M NaCl) containing either
200 mM PMSF or a tablet of complete EDTA-free protease-inhibitor
cocktail (Roche) and 10 ng ml1 DNAse I. Cells were lysed using a
Cell Disruptor (Constant Systems Ltd) applying a pressure of
1.35 MPa and centrifuged for 30 min at 40 000g.
For Ni-affinity purification of the TsaR protein, the amount of
TsaR in the crude lysate was estimated by SDS–PAGE and the
quantity of Ni–NTA Superflow resin (Qiagen) calculated to be
required to bind half of the total TsaR present was then added. After
a short incubation, unbound proteins were removed by three
successive washing steps using lysis buffer containing increasing
concentrations of imidazole (20, 40 and 80 mM) and TsaR was then
eluted with 0.3M imidazole in lysis buffer supplemented with 1M
-mercaptoethanol as in the original literature (Tralau et al., 2003).
The purified protein was concentrated as required using Centricon
YM-10 and Microcon YM-10 concentrators (Amicon, Millipore).
In subsequent preparations, the protocol was optimized in order to
avoid interference from -mercaptoethanol. Ni-affinity chromato-
graphy was preceded by the removal of excess nucleic acids from the
centrifuged lysate by incubation with 0.15% polyethyleneimine (PEI)
pH 7.0 at 277 K for 10 min. Precipitated material was removed by
centrifugation at 40 000g for 30 min and the clarified supernatant was
then filtered through a 0.22 mm membrane (Millex, Millipore) and
immediately purified as described above. This procedure dramatically
improved the quantity and quality of the purified protein. When this
procedure was used, the salt content of all buffers was increased to
0.5M NaCl to maintain the solubility of the protein and 5%(v/v)
glycerol and 5 mM tris(2-carboxyethyl)phosphine (TCEP) were
added to the elution buffer. Owing to the viscosity of the glycerol and
the use of an alternative reducing agent, the corresponding protein
preparations did not require the addition of -mercaptoethanol.
Gel-filtration chromatography (Superdex-200, Pharmacia) showed
that TsaR eluted as a tetramer when purified under the above
conditions.
2.2. Crystallization and preliminary crystal assessment
The first crystals of TsaR were obtained from a sample stored at
253 K in 20% glycerol during a buffer screening aimed at determining
suitable conditions for dialysis of the protein prior to attempting
crystallization. A 2 mg ml1 protein solution mixed with 1M glycine
pH 8, 0.5M NaCl in a 1:1 ratio yielded needle-like crystals after
overnight equilibration at 293 K using the hanging-drop vapour-
diffusion method. These crystals had dimensions of 0.15  0.05 
0.05 mm and diffracted to 12 A˚ resolution using the in-house X-ray
facilities (single rotation-axis diffractometer with a MAR 345 image-
plate detector mounted on a rotating-anode X-ray generator (Cu K,
 = 1.5418 A˚; Fig. 1a). The addition of 100 mM NaI to the crystal-
lization solution improved the quality of the crystals remarkably; they
diffracted to 7 A˚ resolution at the synchrotron (ID14-EH2, ESRF;
Fig. 1b).
Fresh protein was prepared as described above in order to improve
the diffraction quality of the crystals and drops containing 1 ml
5 mg ml1 TsaR solution and 1 ml reservoir solution were set up with
Crystal Screen I (CSI; Hampton Research) at 277 and 293 Kusing the
microbatch-under-oil technique. More than 20% of the 50 conditions
of the screen produced ‘hits’ at 293 K in a few days; these ranged
from crystalline precipitate to visible crystals. A plate-like monoclinic
crystal form appeared in two conditions based on 0.1M sodium
acetate pH 4.6: condition No. 20 [0.2M (NH4)2SO4, 25%(w/v) PEG
4000; Fig. 2c] and condition No. 34 (2M sodium formate; Fig. 2a). In
both conditions the crystals appeared overnight and reached final
dimensions within 3 d. These crystals diffracted to 2.5 A˚ resolution at
the in-house facility (Fig. 3a).
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Figure 1
(a) Initial crystals of TsaR obtained by hanging-drop vapour diffusion in 1M
glycine pH 8.0 and 0.5M NaCl. (b) Optimization of the same conditions by the
addition of 0.1M NaI.
A second crystal form, showing a tetragonal lysozyme-like habit,
appeared in condition No. 11 [1M NH4H2PO4, 0.1M trisodium
citrate pH 5.6) and condition No. 48 (2MNH4H2PO4, 0.1M Tris–HCl
pH 8.5; Fig. 2d), but failed to diffract beyond 7 A˚ resolution using a
synchrotron source (Fig. 3b). At this stage, condition No. 34 was
selected because of the larger size and better reproducibility of the
crystals and the second crystal form was not further optimized.
Crystals from condition No. 34 were also grown in capillaries of 0.2
and 0.3 mm diameter prepared by mixing the protein sample in a 1:1
ratio with low-melting-temperature agarose at 0.2%(w/v) in the same
elution buffer. In some cases a 0.5%(w/v) agarose plug was placed
between the crystallization-condition and the protein chambers
(Fig. 2b). This capillary-based counter-diffusion batch technique
(Garcı´a-Ruiz, 2003) produced crystals of good diffraction quality and
crystallization communications
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Figure 2
Crystals obtained using the microbatch-under-oil technique at 293 K with condition No. 34 of Crystal Screen I (CSI; Hampton Research). (b) The same condition in a 0.2 mm
internal diameter capillary. (c) and (d) Crystals obtained using the microbatch-under-oil technique at 293 K with (c) condition No. 20 and (d) condition No. 48 of CSI.
Table 1
Data-collection statistics for native crystals.
Values in parentheses are for the highest resolution shells.
Data sets Native 1 Native 2 Native 3 Native 4 Native 5 Native 6 Native 7
Source ID14-EH2 In-house† In-house ID14-EH2 In-house BM16 ID14-EH2
Wavelength (A˚) 0.9326 1.5418 1.5418 0.9326 1.5418 1.6059 0.9326
Space group C2 C2 C2 C2 C2 C2 P41212 or P43212
Unit-cell parameters
(A˚, )
a = 135.74, b = 51.39,
c = 108.44,
 = 110.94
a = 136.80, b = 51.88,
c = 109.39,
 = 111.52
a = 135.02, b = 51.49,
c = 108.47,
 = 110.55
a = 134.70, b = 51.74,
c = 108.03,
 = 110.81
a = 135.35, b = 51.77,
c = 109.08,
 = 111.11
a = 136.49, b = 51.48,
c = 107.75,
 = 110.35
a = 204.37, b = 204.37,
c = 336.21
Resolution (A˚) 19.61–1.80
(1.89–180)
49.59–2.67
(2.77–2.67)
47.15–1.79
(1.89–1.79)
48.74–2.11
(2.21–2.11)
47.90–2.01
(2.10–2.01)
32.85–2.51
(2.59–2.51)
49.57–7.10
(7.20–7.10)
Unique reflections 52705 (7371) 20391 (1891) 64424 (8299) 39480 (4244) 43670 (4140) 24352 (2422) 11299 (449)
Redundancy 3.75 (3.76) 3.46 (2.55) 7.03 (5.68) 1.89 (1.60) 5.65 (1.61) 3.87 (3.83) 7.71 (8.14)
Completeness (%) 99.3 (99.1) 98.7 (88.5) 96.6 (81.9) 98.2 (86.0) 95.9 (72.0) 99.9 (100) 99.3 (100)
Rmerge‡ (%) 4.21 (51.32) 4.24 (13.9) 2.98 (18.2) 4.18 (27.8) 5.93 (49.5) 2.99 (13.92) 4.75 (36.03)
Rint (%) 5.53 (57.73) 4.81 (13.03) 5.76 (34.20) 5.79 (20.22) 9.53 (30.49) 3.77 (17.71) 10.58 (60.87)
I/(I) 15.90 (2.14) 16.97 (7.09) 24.62 (5.72) 16.50 (4.13) 11.35 (2.32) 23.49 (7.04) 17.70 (2.95)
† In-house X-ray facilities were a single rotation-axis diffractometer with a MAR 345 image-plate detector mounted on a rotating-anode X-ray generator. ‡ Rmerge =P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ.
facilitated transport to other laboratories, where experiments that
required in situ crystal manipulation prior to data collection were
successfully performed.
Crystals were cryoprotected with solutions prepared for each CSI
condition according to the specified relative crystallization conditions
of Crystal Screen Cryo (Hampton Research) for data collection at
100 K (Garman & Schneider, 1997): 0.16M (NH4)2SO4, 0.08M
sodium acetate pH 4.6, 20%(w/v) PEG 4000 and 20%(v/v) anhydrous
glycerol for condition No. 20, 0.07M sodium acetate pH 4.6, 1.4M
sodium formate and 30%(v/v) anhydrous glycerol for condition No.
34 and 0.08M Tris–HCl pH 8.5, 1.6M NH4H2PO4 and 20%(v/v)
anhydrous glycerol for condition No. 48.
2.3. Data collection and processing
Native and derivative data sets were collected using in-house and
synchrotron X-ray sources from crystals grown in condition No. 34
(Table 1). Native 1 had many reflections missing in the low-resolution
range and a composite data set was therefore prepared with Natives 1
and 2 in order to complement the missing reflections. However, this
could not be used for phasing because the resultant data set was not
isomorphous with the derivatives (data not shown). Native 3 was
collected after a quick soak of a crystal in 1M NaCl in an attempt to
create a more isomorphous data set relative to several halide-
derivatization trials performed with crystals grown in 0.1M NaI
(Native 4) or quick-soaked in 1M NaI (Native 5). Native 6 was
collected on a crystal that had been soaked in samarium(III) acetate
without substitution of the heavy atom.
A data set from a crystal grown in condition No. 48 was collected
using synchrotron radiation (Native 7, Table 1). In spite of the low
resolution, it was possible to determine that it belonged to either
space group P41212 or P43212, with unit-cell parameters a = b = 204.37,
c = 336.21 A˚. From the Matthews coefficient (Matthews, 1968) and
the mechanical fragility of the crystals, the asymmetric unit is likely to
contain three or four tetramers (Matthews coefficient of
3.32 A˚3 Da1 and 63% solvent content with 16 molecules or 72% for
12 molecules in the asymmetric unit). A different asymmetric unit
content cannot be excluded although it appears to be less likely. A
self-rotation function was calculated as a means of supporting one or
the other possibility and two clear peaks of equal intensity at 90%
height from the origin peak were found at ! = 90, ’ = 31 and ! = 90,
’ = 14 and their equivalents. These corresponded to two indepen-
dent noncrystallographic symmetry axes that could relate two pairs of
tetramers in the asymmetric unit (Fig. 4).
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Figure 4
Stereographic projection for a data set collected from a crystal grown using
condition No. 48 of CSI (P41212 or P43212); the  = 180
 section shows two peaks of
equal height (90% of the origin peak) at polar angles ! = 90, ’ = 31 and ! = 90,
’ = 14 . This figure was prepared using XPREP (Sheldrick, 1997).
Figure 3
Diffraction patterns of (a) C2 crystals grown using condition No. 34 of CSI and (b)
P41212 or P43212 crystals grown using condition No. 48 of CSI.
Derivatives were prepared from native crystals grown in condition
No. 34. Two Hg derivatives were obtained by soaking the crystals in
10 mM thimerosal overnight and a xenon derivative was obtained by
pressurizing crystals of TsaR grown in capillaries (Schiltz et al., 2003).
For xenon derivatization, the crystal was transferred to a cryo-
protectant and was then picked up in a cryoloop. The cryoloop was
then placed inside a xenon pressure cell from Hampton Research
(EMBL Hamburg Outstation, Germany) in which a vial of the
cryoprotectant had been previously placed to prevent the crystal
drying out. The cell was pressurized to 2 MPa xenon for 1 min at
293 K. After releasing the pressure over 10–15 s, the sample was
immediately flash-cooled in liquid nitrogen.
Data sets were processed with XDS (Kabsch, 1988) or HKL-2000
(Otwinowski & Minor, 1997) and analysed with XPREP (Sheldrick,
1997).
2.4. Heavy-atom substructure solution for MIRAS
The problems encountered in phasing the structure of TsaR were
largely the consequence of a small but general lack of isomorphism
among the several data sets collected, incompleteness of the low-
resolution range for most of the data sets and for the MAD data set
because of the mounting of the monoclinic crystals along the unique
axis and low substitution of the heavy atoms in each of the deriva-
tives, with a consequent weak anomalous signal.
Attempts to phase TsaR by molecular replacement using the
separate domains of CbnR as search model were unsuccessful.
As the protein contains four cysteine residues, which are
presumably not involved in disulfide bridges, heavy-atom derivati-
zation was chosen rather than the production of a selenomethionine
derivative. A Hg-MAD data set was collected (Hg1, Table 1), but the
incompleteness of the anomalous data required the collection of an
in-house data set (Hg2, Table 1) to combine into a composite Hg data
set (data not shown).
3. Results and discussion
High concentrations of viscous components such as imidazole and
glycerol have proven to be necessary to keep LTTRs in solution in
previous studies (Verschueren et al., 1999; Stec et al., 2004). In the
case of TsaR, the oxygen-sensitivity of the protein posed additional
problems and high concentrations of -mercaptoethanol (1M) were
initially used to keep it stable (Tralau et al., 2003). It was not possible
to dialyse the purified protein into buffers that would be more
suitable for testing a wide range of crystallization conditions,
although the addition of 5% glycerol was effective in reducing the
concentration of -mercaptoethanol to 50 mM or substituting it by
5 mM TCEP. In addition to the presence of the reducing agent, the
exclusion of air was required throughout TsaR preparation and
crystallization, with semi-aerobic culture parameters used in the
overexpression step (limited oxygenation of the growth medium was
achieved by 50% filling of nonbaffled flasks and slow agitation) and
stabilization of the purified protein in viscous buffers. Crystallization
was carried out in batches with limited or no oxygen diffusion.
Indeed, the only techniques that led to diffraction-quality crystals
were the microbatch-under-oil method with 50% silicon and 50%
paraffin oil (Al’s Oil, Hampton Research) and the use of sealed
capillaries.
The batch-capillary technique was used as a means of optimizing
crystallization in condition No. 34 of CSI by further screening the
effect of counter-diffusion. Crystals grew to similar or even larger
sizes than those obtained using the microbatch-under-oil technique,
with the additional advantage that transport of the crystals to other
laboratories or light sources was greatly facilitated.
The high crystallizability shown by TsaR, with crystalline material
being obtained in 20% of the CSI conditions at 293 K, was a conse-
quence of the fragile equilibrium attained by adding high concen-
trations of potential precipitants to the stabilization buffer (organic
solvents and salt). In this case the effectiveness of the buffering
capacity in any given crystallization condition was unclear, since the
imidazole concentration in the protein solution was three times the
concentration of the stabilization buffer. Surprisingly, however, only
crystallization conditions with moderately low pH yielded repro-
ducible crystals. In particular, of the 10% of hits with visible crystals,
only four were reproducible. It is possible that conditions based on
lower salt concentrations and on volatile organic solvents such as
2-propanol were more sensitive to the final imidazole concentration
in the drop and therefore unable to displace the pH of the buffered
TsaR to lower values. It is interesting to note that the TsaR crystal-
lization conditions resemble those described for the C-terminal
domains of two LTTRs: BenM and CatM. In this case, condition No.
20 of the CSI set up using microbatch-under-oil crystallization was
reported to lead to the formation of orthorhombic crystals (Clark et
al., 2004).
Crystallization conditions Nos. 11, 20, 34 and 48 share two common
characteristics: the presence of high concentrations of salt as preci-
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Table 2
Data-collection statistics for derivative crystals.
Values in parentheses are for the highest resolution shells.
Hg1
Data sets Peak Inflection point Remote Hg2 Xe
Source ID29 In-house† BW7A
Wavelength (A˚) 1.0075 1.0088 1.0052 1.5418 0.9763
Space group C2 C2 C2
Unit-cell parameters (A˚, ) a = 134.70, b = 51.74, c = 108.03,  = 110.80 a = 136.52, b = 51.49,
c = 107.74,  = 110.35
a = 136.52, b = 51.49,
c = 107.74,  = 110.36
Resolution (A˚) 19.99–2.40 (2.49–2.40) 19.99–2.40 (2.49–2.40) 19.99–2.40 (2.49–2.40) 19.68–2.63 (2.72–2.63) 20.06–2.47 (2.57–2.47)
Unique reflections 26427 (2746) 26400 (2721) 46852 (4652) 21267 (2041) 24743 (2088)
Redundancy 1.70 (1.68) 1.70 (1.68) 1.70 (1.68) 1.84 (1.82) 1.86 (1.38)
Completeness (%) 95.9 (97.0) 95.9 (96.8) 95.9 (97.0) 99.7 (100) 96.5 (71.5)
Rmerge‡ (%) 7.22 (46.4) 7.23 (43.72) 7.20 (46.96) 12.70 (43.52) 2.43 (19.04)
Rint (%) 7.04 (36.48) 6.61 (35.33) 6.79 (36.18) 10.68 (22.79) 2.38 (12.90)
I/(I) 10.30 (2.36) 10.28 (2.49) 10.35 (2.33) 8.38 (2.53) 30.98 (5.59)
† In-house X-ray facilities were a single rotation-axis diffractometer with a MAR 345 image-plate detector mounted on a rotating-anode X-ray generator. ‡ Rmerge =P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ.
pitant [2M sodium formate and NH4H2PO4 in conditions Nos. 34 and
48, respectively, 1M NH4H2PO4 in condition No. 11 and 0.2M
(NH4)2SO4 in condition No. 20] and a slightly acidic pH between 5
and 6. Despite the sodium acetate buffer at pH 4.6 in conditions Nos.
20 and 34, the final pH values are 5 and 6, respectively. Sodium citrate
buffers condition No. 11 at pH 5.6 and hydrolysis of the ammonium
brings condition No. 48 into the same acid range, despite the presence
of 0.1M Tris–HCl pH 8.5.
The salts NH4H2PO4 and (NH4)2SO4 should be able to form similar
crystal contacts, but they presumably lead to different crystal forms.
Solving the structure of this second crystal form could possibly reveal
patches of positively charged residues that coordinate the PO4
3
present in the crystallization condition, thus mimicking the
DNA–phosphate backbone that interacts with the residues of the
DNA-binding sites. More interestingly, the fact that the analogous
SO4
2-containing salt does not lead the molecules to crystallize in the
same space group suggests a competing effect of the sulfate ligand
with phosphate recognition. This seems to be in accordance with the
modulatory DNA-binding effect observed with TsaR and p-toluene-
sulfonate as co-inducer (Tralau et al., 2003).
The substructures of the two available derivatives were determined
using SHELXD (Sheldrick, 2008). Three Hg positions and a Xe atom
were found and placed with the same origin by cross-difference
Fourier calculations on the phases obtained with the Hg composite
derivative and refined with SHELXE (Sheldrick, 2008) until
convergence was reached. MIRAS phasing and model building are
currently in progress.
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